| BLCM Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the BLCM shares outstanding history going back to 12/18/2014:
Also see: BLCM Market Cap History BLCM YTD Return |
BLCM Shares Outstanding History — Bellicum Pharmaceuticals Share Count Over Time
As of 5/9/2023 Bellicum Pharmaceuticals has 9.50 million BLCM shares outstanding. Investors often track the BLCM shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows BLCM share count trends over time, with 36 historical shares outstanding datapoints presented, dating back to 12/18/2014.
| BLCM Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BLCM Historical Shares Outstanding: +17.36% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BLCM Stock Price Chart |
| About Bellicum Pharmaceuticals Inc |
| Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing controllable cellular immunotherapies for the treatment of various forms of cancer. Co. is developing chimeric antigen receptors (CAR)-T cell therapies, which are an approach in which a patient's or donor's T cells are genetically modified to carry CARs. By incorporating its switch technologies, Co. is developing product candidates in various areas of cellular immunotherapy including BPX-601, which is designed to treat solid tumors expressing prostate stem cell antigen; and BPX-603, which is designed to target solid tumors that express the human epidermal growth factor receptor 2 antigen. We show 36 historical shares outstanding datapoints in our coverage of BLCM's shares outstanding history. Understanding the changing numbers of BLCM shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like BLCM versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching BLCM by allowing them to research BLCM shares outstanding history as well as any other stock in our coverage universe. |
| BLCM Current Stock Quote |
Quotes delayed 20 minutes  Free BLCM Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| BLCM Share Performance |
| Shares Outstanding Peers |
| Bellicum Pharmaceuticals (BLCM) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
BLFS Shares Outstanding History BLI Shares Outstanding History BLPH Shares Outstanding History BLRX Shares Outstanding History BLUE Shares Outstanding History BMEA Shares Outstanding History BMRA Shares Outstanding History BMRN Shares Outstanding History BMY Shares Outstanding History BNBX Shares Outstanding History More Healthcare companies » |
BLCM Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
